A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

Q4 2024 Earnings Call Transcript February 6, 2025 Exponent, Inc. beats earnings expectations. Reported EPS is $0.46, expectations were $0.4. Operator: Good day, and welcome to the Exponent, Inc. Q4 ...